1-3 of 3
Scott R Plotkin
Close
Sort by
Journal Articles

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Clinical Trials & Observations
Matthew J. Frigault, Jorg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst, Scott R. Plotkin, Daniella Cook, Keagan S. Casey, Kevin A. Lindell, Gabriel D. Depinho, Katelin Katsis, Eva Lynn Elder, Mark B. Leick, Bryan Choi, Nora Horick, Frederic Preffer, Meredith Saylor, Steven McAfee, Paul V. O’Donnell, Thomas R. Spitzer, Bimalangshu Dey, Zachariah DeFilipp, Areej El-Jawahri, Tracy T. Batchelor, Marcela V. Maus, Yi-Bin Chen
Journal: Blood
Blood (2022) 139 (15): 2306–2315.
https://doi.org/10.1182/blood.2021014738
Published: 2022
Includes: Supplemental data
Journal Articles

Tisagenlecleucel Demonstrates Safety, Efficacy and CNS Trafficking in Primary CNS Lymphoma

Matthew J. Frigault, Jorg Dietrich, Kathleen M.E. Gallagher, Irene Scarfò, Mark Roschewski, Justin T Jordan, Deborah A. Forst, Scott R Plotkin, Daniella Cook, Keagan Casey, Katelin Katsis, Kevin Lindell, Michael Trailor, Nora Horick, Steven McAfee, Paul V O'Donnell, Thomas R Spitzer, Bimalangshu R Dey, Zachariah Defilipp, Areej El-Jawahri, Tracy Batchelor, Marcela V. Maus, Yi-Bin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 258.
https://doi.org/10.1182/blood-2021-148444
Published: 2021
Journal Articles

High-Dose Methotrexate, Rituximab, and Temozolomide (MRT) for Patients with Primary CNS Lymphoma (PCNSL).

Elizabeth R. Gerstner, Fred H Hochberg, MD, Scott R. Plotkin, April F. Eichler, Tracy T. Batchelor, MD
Journal: Blood
Blood (2009) 114 (22): 1672.
https://doi.org/10.1182/blood.V114.22.1672.1672
Published: 2009